FDA.reportPublic FDA data

efbemalenograstim alfa-vuxw 20 MG per 1 ML Prefilled Syringe

RxCUI
2670662
RxNorm name
efbemalenograstim alfa-vuxw 20 MG per 1 ML Prefilled Syringe
Display name
efbemalenograstim alfa-vuxw 20 MG per 1 ML Prefilled Syringe
Full name
efbemalenograstim alfa-vuxw 20 MG per 1 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761134Ryzneutaefbemalenograstim alfa-vuxw351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
290ed754-758c-9cae-e063-6294a90ae68befbemalenograstim alfa-vuxw 20 MG in 1 ML Prefilled Syringe [PSN] · 1 ML efbemalenograstim alfa-vuxw 20 MG/ML Prefilled Syringe [SCD] · efbemalenograstim alfa-vuxw 20 MG per 1 ML Prefilled Syringe [SY]37These highlights do not include all the information needed to use RYZNEUTA ®safely and effectively. See full prescribing information for RYZNEUTA. RYZNEUTA ®(efbemalenograstim alfa-vuxw) injection, for subcutaneous use Initial U.S. Approval: 202320260519